Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trial to assess the bilateral deficit phenomenon during dynamic plantar flexion task in patients with haemophilic arthropathy Describe the differences in terms of the physical variables (muscular strength, range of motion and proprioception) in patients with hemophilia who have conducted a home treatment with a digital tool.

Bookmark the relationship between clinical history of joint bleeds and clinical manifestations in standing and walking.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exercise Program to Improve Balance in Hemophilic Patients

NCT04122014

Haemophilia

UNKNOWN NA

Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia

NCT07259356

Hemophilia

ENROLLING_BY_INVITATION NA

Individualized Exercise Combined With Manual Therapy in Severe Hemophilia Patients With Polyarthropathy

NCT06535971

Severe Hemophilia

RECRUITING NA

The Effect of Functional Activities and Balance Ability With Taping in Subjects of Hemophilia

NCT02389205

Hemophilia

UNKNOWN NA

The Effects of Exercises on Gait in Hemophilic Individuals

NCT04297696

Hemophilic Arthropathy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Assess the bilateral deficit phenomenon during dynamic plantar flexion task in patients with haemophilic arthropathy.
* Indicate the independent variables that influence the development of strength and contractile activity, with or without previous joint bleeds in haemophilia patients with minors.
* Observe the descriptive variables people influence the standing, the incorporation from sitting and jumping.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with haemophilia

Assessment of bilateral deficit phenomenon during dynamic plantar flexion task

Patients with haemophilia

Intervention Type OTHER

Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients with haemophilia

Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with hemophilia A and B.
* With or without joint involvement clinically diagnosed, and with or without a previous history of hemarthrosis joint load legs.
* In prophylactic regimen with FVIII / FIX concentrates .
* Residents in the Autonomous Community of the Region of Murcia.

Exclusion Criteria

* Patients without walking ability.
* Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).
* Patients with neurological or cognitive impairments that prevent understanding the questionnaires and physical tests.
* Patients whose parents or guardians have not signed the informed consent document.

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No